Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Lymphoma 1Heart Failure 1Cardiotoxicity 1Breast Neoplasms 1

Interventions

Doxorubicin 6Vincristine 4Dexrazoxane 4Razoxane 3Radiotherapy 2Prednisone 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Exercise 2Etoposide 2Cyclophosphamide 2Bleomycin 2pegfilgrastim 1hydrocortisone hemisuccinate 1Vascular Stiffness 1VAP-cyclo protocol 1Secondary Prevention 1Rituximab 1Pulse Wave Analysis 1Prednisolone 1Nebivolol 1Methotrexate 1Methods 1Mercaptopurine 1Leucovorin 1Lenalidomide 1Hydrocortisone 1Electrocardiography 1Echocardiography 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cardiotoxicity × Secondary Prevention × Lymphoid × Clear all
NCT05892146 2023-06-07

Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction

National Cheng-Kung University Hospital

Phase NA Unknown
100 enrolled
BreastLymphoid

Breast Neoplasms, Heart Failure, Lymphoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡